Neilanjan Nandi

473 total citations
23 papers, 301 citations indexed

About

Neilanjan Nandi is a scholar working on Infectious Diseases, Gastroenterology and Epidemiology. According to data from OpenAlex, Neilanjan Nandi has authored 23 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Gastroenterology and 5 papers in Epidemiology. Recurrent topics in Neilanjan Nandi's work include Inflammatory Bowel Disease (5 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and Microscopic Colitis (3 papers). Neilanjan Nandi is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and Microscopic Colitis (3 papers). Neilanjan Nandi collaborates with scholars based in United States, United Kingdom and India. Neilanjan Nandi's co-authors include David Kastenberg, Constantine Daskalakis, Anthony Infantolino, Mitchell Conn, Carol M. Wilson, Jamie S. Barkin, James E. Griffin, Michael J. McPhaul, Shaji Sebastian and Priya Sehgal and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Neilanjan Nandi

23 papers receiving 294 citations

Peers

Neilanjan Nandi
Loren Rabinowitz United States
Pierpaolo Mariani Italy
Daniel J. Friend United States
David Watts United Kingdom
F.D. Petrariu Romania
Richard Harris United Kingdom
Lakshmi Lattimer United States
Jaya Agrawal United States
K. F. Lynch Sweden
Diana Lemos United States
Loren Rabinowitz United States
Neilanjan Nandi
Citations per year, relative to Neilanjan Nandi Neilanjan Nandi (= 1×) peers Loren Rabinowitz

Countries citing papers authored by Neilanjan Nandi

Since Specialization
Citations

This map shows the geographic impact of Neilanjan Nandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neilanjan Nandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neilanjan Nandi more than expected).

Fields of papers citing papers by Neilanjan Nandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neilanjan Nandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neilanjan Nandi. The network helps show where Neilanjan Nandi may publish in the future.

Co-authorship network of co-authors of Neilanjan Nandi

This figure shows the co-authorship network connecting the top 25 collaborators of Neilanjan Nandi. A scholar is included among the top collaborators of Neilanjan Nandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neilanjan Nandi. Neilanjan Nandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sehgal, Priya, et al.. (2025). Safety and Clinical Effectiveness of GLP1 Receptor Agonists in Inflammatory Bowel Disease Patients. Clinical Gastroenterology and Hepatology. 23(8). 1453–1454.e3. 6 indexed citations
2.
Yarur, Andrés, Millie D. Long, Joana Torres, et al.. (2025). Body Mass Index Did Not Affect Efficacy and Safety of Etrasimod: A Post Hoc Analysis of the ELEVATE Ulcerative Colitis Clinical Program. The American Journal of Gastroenterology. 120(11). 2611–2622. 1 indexed citations
3.
Sehgal, Priya, Gary R. Lichtenstein, Octavia Pickett‐Blakely, et al.. (2024). Sa1950 IMPACT OF GLP1 AGONISTS ON INFLAMMATORY BIOMARKERS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Gastroenterology. 166(5). S–591. 5 indexed citations
4.
Ferris, Allison, et al.. (2023). Approach to Diarrhea. Primary Care Clinics in Office Practice. 50(3). 447–459. 2 indexed citations
5.
Nandi, Neilanjan, et al.. (2022). Identifying Care Challenges as Opportunities for Research and Education in Inflammatory Bowel Disease in South Asia. Gastroenterology. 163(5). 1145–1150. 9 indexed citations
6.
Nandi, Neilanjan, et al.. (2021). Social Media and Medical Education in the Context of the COVID-19 Pandemic: Scoping Review. JMIR Medical Education. 7(2). e25892–e25892. 121 indexed citations
7.
Sharma, Vishal, Shrinivas Bishu, Neilanjan Nandi, et al.. (2021). Addressing unmet needs from a new frontier of IBD: the South Asian IBD Alliance. ˜The œLancet. Gastroenterology & hepatology. 6(11). 884–885. 13 indexed citations
8.
Zelenkauskaitė, Asta, et al.. (2021). Reach and Power of Physician-Initiated Tweets in a Twitter Inflammatory Bowel Disease Community. Crohn s & Colitis 360. 3(3). otab052–otab052. 4 indexed citations
9.
Patel, Dhruvan, et al.. (2019). Tu1877 – Fecal Microbiota Transplantation (FMT) for Irritable Bowel Syndrome (IBS): A Systematic Review and Meta-Analysis. Gastroenterology. 156(6). S–1156. 1 indexed citations
10.
Lee, Andrew, et al.. (2019). Sa1629 – The Risk Factors and Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease. Gastroenterology. 156(6). S–1260. 2 indexed citations
11.
Perimbeti, Stuthi, et al.. (2019). Impact of clostridium difficile infection on gastrointestinal malignancies.. Journal of Clinical Oncology. 37(4_suppl). 170–170. 1 indexed citations
12.
Shah, Shefali, et al.. (2017). Anonymous Self Perception Survey of Sexuality and Body Image in Inflammatory Bowel Disease. The American Journal of Gastroenterology. 112. S377–S380. 1 indexed citations
13.
Woloszynek, Stephen, Steven Pastor, Joshua Chang Mell, et al.. (2016). Engineering Human Microbiota: Influencing Cellular and Community Dynamics for Therapeutic Applications. International review of cell and molecular biology. 324. 67–124. 11 indexed citations
14.
Nandi, Neilanjan, et al.. (2013). Improving hip fracture care: striving for excellence. Reviews in Clinical Gerontology. 23(3). 223–233. 3 indexed citations
15.
Barkin, Jodie A., et al.. (2012). Superiority of the DNA Amplification Assay for the Diagnosis of C. difficile Infection: A Clinical Comparison of Fecal Tests. Digestive Diseases and Sciences. 57(10). 2592–2599. 11 indexed citations
16.
Nandi, Neilanjan, et al.. (2012). GI Crossword: Puzzle. Clinical and Translational Gastroenterology. 3(11). e25–e25. 4 indexed citations
17.
18.
19.
Wilson, Carol M., et al.. (2002). Immunoreactive AR and Genetic Alterations in Subjects with Androgen Resistance and Undetectable AR Levels in Genital Skin Fibroblast Ligand-Binding Assays. The Journal of Clinical Endocrinology & Metabolism. 87(1). 182–188. 15 indexed citations
20.
Nandi, Neilanjan, et al.. (1976). Oxidation of ephedrine in rat brain.. PubMed. 14(6). 663–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Loren Rabinowitz Breakdown of academic impact, for papers by Pierpaolo Mariani Breakdown of academic impact, for papers by Daniel J. Friend Breakdown of academic impact, for papers by David Watts Breakdown of academic impact, for papers by F.D. Petrariu Breakdown of academic impact, for papers by Richard Harris Breakdown of academic impact, for papers by Lakshmi Lattimer Breakdown of academic impact, for papers by Jaya Agrawal Breakdown of academic impact, for papers by K. F. Lynch Breakdown of academic impact, for papers by Diana Lemos
Rankless by CCL
2026